PFSA insider trading
NasdaqGM HealthcareProfusa, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Profusa, Inc.
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Company website: profusa.com
PFSA insider activity at a glance
FilingIQ has scored 19 insider transactions for PFSA since Jan 26, 2026. The most recent filing in our index is dated May 4, 2026.
Across the full history, 2 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for PFSA?
- FilingIQ tracks 19 Form 4 insider transactions for PFSA (Profusa, Inc.), covering filings from Jan 26, 2026 onwards. 2 of those were filed in the last 90 days.
- Are PFSA insiders net buyers or net sellers?
- Across the full Form 4 history for PFSA, 2 transactions (11%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PFSA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is PFSA in?
- Profusa, Inc. (PFSA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $2.27M.
Methodology & sources
Every PFSA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.